EMCC European Monitoring Centre on Change



Geographic Location

Country: Czechia
Region: Moravskoslezsky; Moravskoslezsko
Location of affected unit(s): Ostrava


Sector: Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21.20 - Manufacture of pharmaceutical preparations

Employment Effects

Announcement Date: 19-03-2013
Type of Restructuring: Business expansion
Foreseen End Date: 31-12-2013
Planned Job Creation: 150

Additional Information

PrimeCell, a global company working in the field of regenerative medicine, is to set up an international centre in Ostrava and to create 150 new jobs by the end of 2013. With the help of European subsidies, the centre 4MEDi-Biotech Park for Medical Innovations will develop products from human cells for the treatment of inadequately treated or incurable diseases such as multiple sclerosis, Alzheimer´s disease or diabetes. The investment of the project amounted to a total of CZK 702 million.